Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Patients taking prescription SNRIs should treat BPC-157 as an uncharacterized compound when evaluating polypharmacy risk
Presented for research literature review only Isono M et al
Looking to source GHK-Cu
The peptide itself is prepared by a licensed compounding pharmacy, since the original FDA-approved drug is no longer manufactured or sold
US$ 25.04
US$ 25.82
US$ 29.67
US$ 22.49
US$ 23.68
US$ 1689.99
Sold : Login>>
